Mom and daughter promote kindness adventures through new book
— CNN.com – RSS Channel – US
News Now!
Author: Michelle Dryden
Michelle Dryden has come full-circle back to the exciting world of Journalism, news, and media. Dryden is an Independent Multimedia Journalist. She graduated with honors from Full Sail University. Dryden received the Advanced Achievement Award from Full Sail University's New Media Journalism Master's degree program, in June 2013. With journalism experiences in both digital and traditional journalism since 1996, she is a news veteran. The Media Pub News blog publishes core news and community features. What's your story? Email me at mdryden@themediapub.com. Cheers!!!
Cultural Corner, News Now!
Marine’s identity stolen to scam ladies looking for love
St. Louis, MO (KMOV) — Lockdowns can be lonely; the pandemic has been keeping people away from loved ones and even from finding new love. That’s causing scammers to strike. Experts say catfishing is on the rise during the COVID-19 crisis. A
Business, Health Care
Unilever to acquire SmartyPants Vitamins
ENGLEWOOD CLIFFS, N.J.–(BUSINESS WIRE)–Unilever announced today that it has signed an agreement to acquire SmartyPants Vitamins, a U.S.-based Vitamin, Mineral & Supplement company. Based in Los Angeles, SmartyPants Vitamins was founded in 2011 by entrepreneurs Courtney Nichols Gould and Gordon Gould, who
Business
Hudson announces “Celebrate Books and Booksellers”
The Campaign Celebrates the Power of Reading and Finding Solace in Books Throughout 2020 EAST RUTHERFORD, N.J.–(BUSINESS WIRE)–Hudson Ltd. (NYSE: HUD) (“Hudson” or “Company”), a North American travel experience leader with more than 1,000 stores in airports, commuter hubs, landmarks and tourist
News Now!, Politics
Pandemic’s fiscal toll on New York City: 5 takeaways
The city is already facing a nearly $4 billion budget gap next year, as recovery efforts from the coronavirus are hampered by evidence of a second wave. Although the city has shown signs of slowly recovering from an economic crisis caused by
Business, Health Care, Local News
Bristol Myers Squibb receives European Commission approval for Opdivo (nivolumab) as second-line treatment for unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma
First immunotherapy to be approved for a gastroesophageal cancer in the European Union Approval based on Phase 3 ATTRACTION-3 trial showing statistically significant and clinically meaningful improvement in overall survival compared to chemotherapy PRINCETON, N.J.–(BUSINESS WIRE)–$BMY #BMS—Bristol Myers Squibb (NYSE: BMY) today